Supply Chain and Quality Operations in Ireland
New Dublin Facility Will Serve Patients with Life-Threatening Ultra-Rare Disorders in 50 Countries
Dublin - The Minister for Jobs, Enterprise and Innovation Richard Bruton, TD today announced that Alexion Pharmaceuticals is expanding its global presence with the opening of a new office and laboratory facility in Dublin in conjunction with the companys decision to establish a global supply chain facility in Ireland. Alexion has begun the process of recruiting approximately 50 employees by year-end for a range of initial positions in its supply chain, quality assurance, quality control and logistics functions by year-end.
Alexions new, additional global supply chain and quality staff in Ireland are expected to begin supplying Soliris® (eculizumab) to patients with PNH and aHUS, two severe and life-threatening ultra-rare disorders, by the end of 2013. The companys expanding Irish workforce will also manage the supply of additional Alexion medicines to patients following regulatory approvals for a series of anticipated launches of new therapies over the next several years. Todays announcement is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
Read full press release here